Pharmalot… Pharmalittle… Evening Edition

Make a comment

dog-run.jpgAnother busy day draws to a close, which means the time has come to pursue other activities, such as meandering over to the dog run so Pharmapooch can stretch his legs. Pharmalot, in fact, would like to do the same. Meanwhile, there’s much to peruse. We hope you enjoy them…

Off-Label Use Denied Medicare Part D Patients (USA Today)

Public Citizen Urges Congress To Act On Clinical Trial Registries (PharmaTimes)

Wyeth’s Prevnar Hiked 6.5 Percent (AAP News - subscription required)

Novartis Haggles Over Procedural Issues In Gleevac Case (The Economic Times)

And here are today’s earliest items on Pharmalot, in case you missed them:

Another Headache For Glaxo And Pozen

FDA Retention Bonuses Favor The Brass

Deadly Dilemma: Cancer And FDA Approval

Bristol-Myers’ Orencia Isn’t NICE Enough

Jump to comments

Share

Comments are closed.

Subscribe

RSS Feed

Comments feed for this post only.

Tags

Clear

Clear

© 2007- 2008 Newark Morning Ledger Co.  All Rights Reserved.

Thanks for trying out the new Pharmalot printing tools. If you're got any suggestions for how we can help you print better, please let us know by clicking on the contact link at http://www.pharmalot.com/